Up-regulation of hexokinase1 in the right ventricle of monocrotaline induced pulmonary hypertension

Respiratory Research

Volumn 15, Issue 1, 2014, Pages

  Zhang, Wei Hua ^a   Qiu, Mei Hong ^b   Wang, Xiao Jian ^c   Sun, Kai ^c   Zheng, Yang ^a   Jing, Zhi Cheng ^c  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c FUWAI HOSPITAL   (China)

Author keywords

Glycolysis; Hexokinase 1; Pulmonary hypertension; Right heart failure

Indexed keywords

HEXOKINASE 1; LACTATE DEHYDROGENASE; MESSENGER RNA; MONOCROTALINE; PYRUVATE DEHYDROGENASE COMPLEX; HEXOKINASE; HK1 PROTEIN, MOUSE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CONTROLLED STUDY; ENZYME INDUCTION; GENE EXPRESSION; GLYCOLYSIS; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; MALE; NONHUMAN; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; HEART VENTRICLE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; HEART VENTRICLES; HEXOKINASE; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84927767199     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/s12931-014-0119-9     Document Type: Article

References (17)

1. Humbert M, Sitbon O, Simonneau G: Treatment of pulmonary arterial hypertension. N Engl J Med. 2004, 351: 1425-1436. 10.1056/NEJMra040291.
2. Gomez-Arroyo J, Sandoval J, Simon MA, Dominguez-Cano E, Voelkel NF, Bogaard HJ: Treatment for pulmonary arterial hypertension-associated right ventricular dysfunction.Ann Am Thorac Soc 2014, [Epub ahead of print].,
3. Vonk-Noordegraaf A, Haddad F, Chin KM, Forfia PR, Kawut SM, Lumens J, Naeije R, Newman J, Oudiz RJ, Provencher S, Torbicki A, Voelkel NF, Hassoun PM: Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013, 62: D22-D33. 10.1016/j.jacc.2013.10.027.
4. Can MM, Kaymaz C, Tanboga IH, Tokgoz HC, Canpolat N, Turkyilmaz E, Sonmez K, Ozdemir N: Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med. 2011, 36: 743-748. 10.1097/RLU.0b013e3182177389.
5. Oikawa M, Kagaya Y, Otani H, Sakuma M, Demachi J, Suzuki J, Takahashi T, Nawata J, Ido T, Watanabe J, Shirato K: Increased [18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005, 45: 1849-1855. 10.1016/j.jacc.2005.02.065.
6. Marsboom G, Wietholt C, Haney CR, Toth PT, Ryan JJ, Morrow E, Thenappan T, Bache-Wiig P, Piao L, Paul J, Chen CT, Archer SL: Lung (1) (8) F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012, 185: 670-679. 10.1164/rccm.201108-1562OC.
7. Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, Lopaschuk GD, Archer SL: The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med. 2010, 88: 47-60. 10.1007/s00109-009-0524-6.
8. Michelakis ED, McMurtry MS, Wu XC, Dyck JR, Moudgil R, Hopkins TA, Lopaschuk GD, Puttagunta L, Waite R, Archer SL: Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels. Circulation. 2002, 105: 244-250. 10.1161/hc0202.101974.
9. Fang YH, Piao L, Hong Z, Toth PT, Marsboom G, Bache-Wiig P, Rehman J, Archer SL: Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle. J Mol Med. 2012, 90: 31-43. 10.1007/s00109-011-0804-9.
10. Piao L, Sidhu VK, Fang YH, Ryan JJ, Parikh KS, Hong Z, Toth PT, Morrow E, Kutty S, Lopaschuk GD, Archer SL: FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. J Mol Med. 2013, 91: 333-346. 10.1007/s00109-012-0982-0.
11. Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshit A: Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res. 2004, 94: 385-393. 10.1161/01.RES.0000111804.34509.94.
12. Liao CM, Li J, Liu XH, Zhang YS: An effective method for extracting total RNA from Dioscorea opposita Thunb. Genet Mol Res. 2014, 13: 462-468. 10.4238/2014.January.21.15.
13. Drake JI, Bogaard HJ, Mizuno S, Clifton B, Xie B, Gao Y, Dumur CI, Fawcett P, Voelkel NF, Natarajan R: Molecular signature of a right heart failure program in chronic severe pulmonary hypertension. Am J Respir Cell Mol Biol. 2011, 45: 1239-1247. 10.1165/rcmb.2010-0412OC.
14. Rehman J, Archer SL: A proposed mitochondrial-metabolic mechanism for initiation and maintenance of pulmonary arterial hypertension in fawn-hooded rats: the Warburg model of pulmonary arterial hypertension. Adv Exp Med Biol. 2010, 661: 171-185. 10.1007/978-1-60761-500-2_11.
15. Bonnet S, Michelakis ED, Porter CJ, Andrade-Navarro MA, Thebaud B, Haromy A, Harry G, Moudgil R, McMurtry MS, Weir EK, Archer SL: An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation. 2006, 113: 2630-2641. 10.1161/CIRCULATIONAHA.105.609008.
16. Guignabert C, Tu L, Izikki M, Dewachter L, Zadigue P, Humbert M, Adnot S, Fadel E, Eddahibi S: Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter. FASEB J. 2009, 23: 4135-4147. 10.1096/fj.09-131664.
17. McMurtry MS, Bonnet S, Wu X, Dyck JR, Haromy A, Hashimoto K, Michelakis ED: Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. Circ Res. 2004, 95: 830-840. 10.1161/01.RES.0000145360.16770.9f.